Adrian Rawcliffe - Insider Trading Tracker

Introduction

This page provides a comprehensive analysis of the known insider trading history of Adrian Rawcliffe. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

Companies with Reported Insider Positions

The SEC filings indicate Adrian Rawcliffe has reported holdings or trades in the following companies:

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Adrian Rawcliffe. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
2025-01-17	ADAP	Rawcliffe Adrian	30,601	0.5808	30,601	0.5808	17,773	231	0.0410	-16,518	-92.94
2025-01-15	ADAP	Rawcliffe Adrian	29,096	0.5748	29,096	0.5748	16,724
2025-01-13	ADAP	Rawcliffe Adrian	12,539	0.5879	12,539	0.5879	7,372
2025-01-13	ADAP	Rawcliffe Adrian	17,934	0.5879	17,934	0.5879	10,543
2024-01-17	ADAP	Rawcliffe Adrian	30,080	0.6730	30,080	0.6730	20,244
2024-01-16	ADAP	Rawcliffe Adrian	9,304	0.7900	9,304	0.7900	7,350
2024-01-12	ADAP	Rawcliffe Adrian	17,257	0.8541	17,257	0.8541	14,739
2024-01-11	ADAP	Rawcliffe Adrian	11,945	0.8367	11,945	0.8367	9,994
2023-09-01	ADAP	Rawcliffe Adrian	2,403	0.7800	2,403	0.7800	1,874
2023-06-27	ADAP	Rawcliffe Adrian	2,333	0.9200	2,333	0.9200	2,146
2023-01-17	ADAP	Rawcliffe Adrian	10,057	1.8580	10,057	1.8580	18,686
2023-01-12	ADAP	Rawcliffe Adrian	18,763	1.7060	18,763	1.7060	32,010
2023-01-11	ADAP	Rawcliffe Adrian	13,042	1.7468	13,042	1.7468	22,782
2023-01-04	ADAP	Rawcliffe Adrian	5,073	1.6940	5,073	1.6940	8,594
2022-09-01	ADAP	Rawcliffe Adrian	2,536	1.9689	2,536	1.9689	4,993
2022-06-27	ADAP	Rawcliffe Adrian	2,562	1.6300	2,562	1.6300	4,176
2022-01-18	ADAP	Rawcliffe Adrian	11,096	3.1918	11,096	3.1918	35,416
2022-01-12	ADAP	Rawcliffe Adrian	3,046	3.5441	3,046	3.5441	10,795
2022-01-11	ADAP	Rawcliffe Adrian	14,362	3.5567	14,362	3.5567	51,081
2022-01-04	ADAP	Rawcliffe Adrian	5,532	4.0642	5,532	4.0642	22,483
2021-09-01	ADAP]	Rawcliffe Adrian	2,782	5.1950	2,782	5.1950	14,452
2021-06-28	ADAP	Rawcliffe Adrian	2,794	4.3700	2,794	4.3700	12,210
2021-01-19	ADAP	Rawcliffe Adrian	9,879	5.6695	9,879	5.6695	56,009
2021-01-12	ADAP	Rawcliffe Adrian	2,707	6.1522	2,707	6.1522	16,654
2021-01-04	ADAP	Rawcliffe Adrian	4,967	5.3279	4,967	5.3279	26,464
2020-09-01	ADAP	Rawcliffe Adrian	2,776	8.5149	2,776	8.5149	23,637
2020-08-03	ADAP	Rawcliffe Adrian	2,788	9.2500	2,788	9.2500	25,789
2020-01-14	ADAP	Rawcliffe Adrian	3,236	5.1347	3,236	5.1347	16,616
2020-01-06	ADAP	Rawcliffe Adrian	5,900	1.2000	5,900	1.2000	7,080
2019-01-14	ADAP	Rawcliffe Adrian	3,084	5.3694	3,084	5.3694	16,559
2018-03-20	ADAP	Rawcliffe Adrian	600,000	1.7100	600,000	1.7100	1,026,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Purchases WVE / Wave Life Sciences Ltd. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales WVE / Wave Life Sciences Ltd. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Adrian Rawcliffe as disclosed to the Securities Exchange Commission (SEC).